Dose-finding Study of Moxidectin for Treatment of Scabies
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The effective dose of moxidectin to treat human scabies is not known. This study aims to
provide proof of concept that a single dose of moxidectin is effective in eliminating the
scabies parasite in humans and to enable the determination of an optimal dose of moxidectin
for treatment of scabies for further clinical studies.
Phase:
Phase 2
Details
Lead Sponsor:
Medicines Development for Global Health Medicines Development Limited